BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF
170 results:

  • 1. Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors.
    Cosyns S; Van Moer E; De Quick I; Tournaye H; De Vos M
    Arch Gynecol Obstet; 2024 May; 309(5):2143-2152. PubMed ID: 38494510
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ethical, legal, social, and policy issues of ovarian tissue cryopreservation in prepubertal girls: a critical interpretive review.
    Affdal AO; Salama M; Ravitsky V
    J Assist Reprod Genet; 2024 Apr; 41(4):999-1026. PubMed ID: 38430324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fertility counselling and fertility preservation among early onset female cancer patients-A Finnish register-based study.
    Melin J; Holopainen E; Savolainen-Peltonen H
    Cancer Med; 2024 Feb; 13(3):e7034. PubMed ID: 38400669
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Perceptions and experiences of fertility preservation in female patients with cancer in Greece.
    Taniskidou AM; Voultsos P; Tarlatzis V; Timotheadou E
    BMC Womens Health; 2024 Feb; 24(1):108. PubMed ID: 38336757
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Survey on the implementation status and reproductive outcomes of oocyte and ovarian tissue cryopreservation in Japan: Historical comparison with nationwide surveys.
    Takae S; Harada M; Nakamura K; Furuyama S; Ono M; Osuga Y; Suzuki N
    J Obstet Gynaecol Res; 2024 Apr; 50(4):709-718. PubMed ID: 38263596
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?
    Benvenuti C; Laot L; Grinda T; Lambertini M; Pistilli B; Grynberg M
    ESMO Open; 2024 Feb; 9(2):102228. PubMed ID: 38232611
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Current Position of Oncofertility in Adolescent Female cancer Patients: A Comparative Review on Society Guidelines.
    Park SJ; Han JY; Kim SW; Kim H; Ku SY
    In Vivo; 2024; 38(1):48-57. PubMed ID: 38148044
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fertility preservation before and after cancer treatment in children, adolescents, and young adults.
    Yang EH; Strohl HB; Su HI
    Cancer; 2024 Feb; 130(3):344-355. PubMed ID: 37962199
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients.
    Barral Y; Borrás A; Carrillo P; Agustí I; Peralta S; Casals G; Fàbregues F; Guimerà M; Corral JM; Calafell JM; Redondo M; Glickman A; Rovira M; Adamo B; Ricart E; Trullàs DM
    Clin Transl Oncol; 2024 May; 26(5):1129-1138. PubMed ID: 37872422
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fertility preservation in patients with gynaecologic malignancy: Response to ovarian stimulation and long-term outcomes.
    Tsonis O; Kopeika J
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():93-100. PubMed ID: 37757729
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
    Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
    J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Preservation of fertility in female patients with hematologic diseases.
    Antunes MB; Cardeal SP; Magalhães M; Vale-Fernandes E; Barreiro M; Sá R; Sousa M
    Blood Rev; 2023 Nov; 62():101115. PubMed ID: 37562987
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Outcomes of Fertility Preservation for Female cancer Patients in a Single Tertiary Center.
    Kim JH; Alzahrani HS; Lee SR; Kim SH; Chae HD
    Yonsei Med J; 2023 Aug; 64(8):497-504. PubMed ID: 37488701
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation.
    Zhao W; Sun P; Li T; Li Y; Liang X; Li J
    Int J Gynaecol Obstet; 2023 Nov; 163(2):645-650. PubMed ID: 37265085
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. DuoStim protocol- a novel fertility preservation strategy for female oncology patients.
    Puthur SJ; Tracey S; Gould D; Fitzgerald CT
    Hum Fertil (Camb); 2023 Dec; 26(5):1361-1367. PubMed ID: 36999567
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Do Fertility Preservation Outcomes in Patients Diagnosed with Lymphoma Differ Based on cancer Stage?
    Kocsuta V; Shah S; Lawson AK; Pavone ME
    J Adolesc Young Adult Oncol; 2024 Apr; 13(2):300-306. PubMed ID: 36809174
    [No Abstract]    [Full Text] [Related]  

  • 17. Fertility Preservation Practices at Pediatric Oncology Institutions in the United States: A Report From the Children's Oncology Group.
    Frederick NN; Klosky JL; Meacham L; Quinn GP; Kelvin JF; Cherven B; Freyer DR; Dvorak CC; Brackett J; Ahmed-Winston S; Bryson E; Su HI; Chow EJ; Levine J
    JCO Oncol Pract; 2023 Apr; 19(4):e550-e558. PubMed ID: 36763922
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
    Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
    J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Survey of understanding and awareness of fertility preservation in pediatric patients: Is conversation about fertility preservation unpleasant for pediatric patients?
    Takae S; Iwahata Y; Sugishita Y; Iwahata H; Kanamori R; Shiraishi E; Ito K; Suzuki Y; Yamaya Y; Tanaka K; Oyama K; Keino D; Nakamura K; Odawara K; Horage Y; Meng L; Igualada A; Faizal AM; Aworet LO; Furuta S; Sakamoto M; Mori T; Kitagawa H; Suzuki N
    Front Endocrinol (Lausanne); 2022; 13():1074603. PubMed ID: 36686445
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibiting the growth of ovarian cancer cells in vitro and in vivo by a small molecular inhibitor targeting La-RNA interactions.
    Li Y; Huang X; Tang J
    Eur J Pharmacol; 2023 Feb; 940():175471. PubMed ID: 36549502
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.